The fatigue after infusion or transfusion pilot trial and feasibility study: A three‐armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia
Transfusion · 2024
DOI: 10.1111/trf.17621 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Transfusion, 2024. Verfasst von Esther Caljé und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liggins Institute, The University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Anemia, Erythrocyte Transfusion, Hematinics, Postpartum Period. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Background
Evidence for the management of moderate‐to‐severe postpartum anemia is limited. A randomized trial is needed; recruitment may be challenging. Study Design and Methods Randomized pilot trial with feasibility surveys. Inclusion : hemoglobin 65–79 g/L, ≤7 days of birth, hemodynamically stable. Exclusion : ongoing heavy bleeding; already received, or contraindication to intravenous (IV)‐iron or red blood cell transfusion (RBC‐T). Intervention/control : IV‐iron; RBC‐T; or IV‐iron and RBC‐T. Primary outcome: number of recruits; proportion of those approached; proportion considered potentially eligible. Secondary outcomes : fatigue, depression, baby‐feeding, and hemoglobin at 1, 6 and 12 weeks; ferritin at 6 and 12 weeks. Surveys explored attitudes to trial participation.
Results
Over 16 weeks and three sites, 26/34 (76%) women approached consented to trial participation, including eight (31%) Māori women. Of those potentially eligible, 26/167 (15.6%) consented to participate. Key participation enablers were altruism and study relevance. For clinicians and stakeholders the availability of research assistance was the key barrier/enabler. Between‐group rates of fatigue and depression were similar. Although underpowered to address secondary outcomes, IV‐iron and RBC‐T compared with RBC‐T were associated with higher hemoglobin concentrations at 6 (mean difference [MD] 11.7 g/L, 95% confidence interval [CI] 2.7–20.7) and 12 (MD 12.8 g/L, 95% CI 1.5–24.2) weeks, and higher ferritin concentrations at 6 weeks (MD 136.8 mcg/L, 95% CI 76.6–196.9).
Discussion
Willingness to participate supports feasibility for a future trial assessing the effectiveness of IV‐iron and RBC‐T for postpartum anemia. Dedicated research assistance will be critical to the success of an appropriately powered trial including women‐centered outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liggins Institute, The University of Auckland, Auckland, New Zealand.
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, The University of Auckland, Auckland, New Zealand.
- Middlemore Hospital, Auckland, New Zealand.
- New Zealand College of Midwives, Christchurch, New Zealand.
- National Women's Health, Auckland City Hospital, Auckland, New Zealand.
ORCID-Profile: Esther Caljé
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Caljé, E., Oyston, C., Wang, Z., Bloomfield, F., Marriott, J., Dixon, L., & Groom, K. (2024). The fatigue after infusion or transfusion pilot trial and feasibility study: A three‐armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia. Transfusion. https://doi.org/10.1111/trf.17621
Vancouver
Caljé E, Oyston C, Wang Z, Bloomfield F, Marriott J, Dixon L, et al. The fatigue after infusion or transfusion pilot trial and feasibility study: A three‐armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia. Transfusion. 2024. doi:10.1111/trf.17621
BibTeX
@article{Calj2024,
author = {Caljé, Esther and Oyston, Charlotte and Wang, Zeke and Bloomfield, Frank and Marriott, Joy and Dixon, Lesley and Groom, Katie},
title = {The fatigue after infusion or transfusion pilot trial and feasibility study: A three‐armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17621}
}
EUVIMED